{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:33:52Z","timestamp":1788348832029,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["neuromodulationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromodulation: Technology at the Neural Interface"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1111\/ner.12146","type":"journal-article","created":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T10:37:37Z","timestamp":1390300657000},"page":"354-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"title":["Best Practices for Intrathecal Drug Delivery for Pain"],"prefix":"10.1016","volume":"17","author":[{"given":"Joshua","family":"Prager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Deer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Bruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Buchser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Caraway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cousins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"McGlothlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Rauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Staats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Stearns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ner.12146_bib1","first-page":"516","article-title":"Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin","volume":"56","author":"Onofrio","year":"1981","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/ner.12146_bib2","series-title":"Medtronic marketing data","year":"2013"},{"key":"10.1111\/ner.12146_bib3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00000542-198409000-00008","article-title":"Intrathecal and epidural administration of opioids","volume":"61","author":"Cousins","year":"1984","journal-title":"Anesthesiology"},{"key":"10.1111\/ner.12146_bib4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0885-3924(97)00166-8","article-title":"Clinical realities and economic considerations: patient selection in intrathecal therapy","volume":"14","author":"Krames","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/ner.12146_bib5","unstructured":"Joint Commission on Accreditation of Healthcare Organizations. Comprehensive Accreditation Manual for Ambulatory Care. 1999\u20132000."},{"key":"10.1111\/ner.12146_bib6","unstructured":"International Association for the Study of Pain. Declaration of Montreal. http:\/\/www.iasp-pain.org\/Content\/NavigationMenu\/Advocacy\/DeclarationofMontr233al\/default.htm. Accessed Dec. 9, 2013."},{"key":"10.1111\/ner.12146_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1525-1403.1999.00055.x","article-title":"Intrathecal therapy for cancer and nonmalignant pain: patient selection and patient management","volume":"2","author":"Deer","year":"2002","journal-title":"Neuromodulation"},{"key":"10.1111\/ner.12146_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1526-4637.2004.04011.x","article-title":"Intrathecal drug delivery for treatment of chronic low back pain: report from the National Outcomes Registry for Low Back Pain","volume":"5","author":"Deer","year":"2004","journal-title":"Pain Med"},{"key":"10.1111\/ner.12146_bib9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0885-3924(93)90118-F","article-title":"Intrathecal infusional therapies for intractable pain: patient management guidelines","volume":"8","author":"Krames","year":"1993","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/ner.12146_bib10","series-title":"Medtronic 2011 product performance report","year":"2011"},{"key":"10.1111\/ner.12146_bib11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/ALN.0b013e3181b64ab8","article-title":"Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat non-cancer pain","volume":"111","author":"Coffey","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1111\/ner.12146_bib12","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/ALN.0b013e3181b64afa","article-title":"Death after initiation of intrathecal drug therapy for chronic pain","volume":"111","author":"Rathmell","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1111\/ner.12146_bib13","doi-asserted-by":"crossref","first-page":"E175","DOI":"10.36076\/ppj.2010\/13\/E175","article-title":"Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery","volume":"13","author":"Deer","year":"2010","journal-title":"Pain Physician"},{"key":"10.1111\/ner.12146_bib14","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1526-4637.2010.00886.x","article-title":"A critical time for practice change in the pain treatment continuum: we need to reconsider the role of pumps in the patient care algorithm","volume":"11","author":"Deer","year":"2010","journal-title":"Pain Med"},{"key":"10.1111\/ner.12146_bib15","unstructured":"Prager JP. Minimizing the risks of intrathecal therapy. Lecture, Scientific Meeting of The North American Neuromodulation Society. 2009."},{"key":"10.1111\/ner.12146_bib16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jpainsymman.2004.03.001","article-title":"Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery\u2014report of an expert panel","volume":"27","author":"Hassenbusch","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/ner.12146_bib17","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.2146\/ajhp060204","article-title":"Intrathecal drug therapy for long-term pain management","volume":"64","author":"Ghafoor","year":"2007","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1111\/ner.12146_bib18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/ALN.0b013e31818ec946","article-title":"Practice guidelines for the prevention, detection, and management of respiratory depression associated with neuraxial opioid administration","volume":"110","author":"Horlocker","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1111\/ner.12146_bib19","series-title":"NCHS data brief, no 22","first-page":"1","article-title":"Increase in fatal poisonings involving opioid analgesics in the United States, 1999\u20132006","author":"Warner","year":"2009"},{"key":"10.1111\/ner.12146_bib20","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1526-4637.2010.00889.x","article-title":"Medical practice perspective: identification and mitigation of risk factors for mortality associated with intrathecal opioids for non-cancer pain","volume":"11","author":"Coffey","year":"2010","journal-title":"Pain Med"},{"key":"10.1111\/ner.12146_bib21","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMra025411","article-title":"Opioid therapy for chronic pain","volume":"349","author":"Ballantyne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/ner.12146_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/104990910402100214","article-title":"The conversion challenge: from intrathecal to oral morphine","volume":"21","author":"Sylvester","year":"2004","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1111\/ner.12146_bib23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.spmd.2003.10.001","article-title":"The dilemma of opioid conversion in intrathecal therapy","volume":"1","author":"DuPen","year":"2003","journal-title":"Sem Pain Med"},{"key":"10.1111\/ner.12146_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(92)90192-E","article-title":"Individual variability in the response to different opioids: report of five cases","volume":"49","author":"Galer","year":"1992","journal-title":"Pain"},{"key":"10.1111\/ner.12146_bib25","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1525-1403.2007.00128.x","article-title":"Polyanalgesic Consensus Conference 2007: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel","volume":"10","author":"Deer","year":"2007","journal-title":"Neuromodulation"},{"key":"10.1111\/ner.12146_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0885-3924(96)00010-3","article-title":"Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guidelines","volume":"11","author":"Krames","year":"1996","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/ner.12146_bib27","series-title":"Infumorph 200, Infumorph 500 [package insert]","year":"2011"},{"key":"10.1111\/ner.12146_bib28","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1017\/S026502150600038X","article-title":"Opioid-related side-effects after intrathecal morphine: a prospective, randomized, double-blind dose-response study","volume":"23","author":"Raffaeli","year":"2006","journal-title":"Eur J Anesthes"},{"key":"10.1111\/ner.12146_bib29","first-page":"399","article-title":"Intrathecal drug delivery for management of cancer pain. A multidisciplinary consensus of best clinical practices","volume":"3","author":"Stearns","year":"2005","journal-title":"J Supportive Oncol"},{"key":"10.1111\/ner.12146_bib30","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1213\/ane.0b013e3181606fad","article-title":"Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trial","volume":"106","author":"Wallace","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1111\/ner.12146_bib31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1533-2500.2008.00187.x","article-title":"Patient-controlled analgesia in chronic pain patients: experience with a new device designed to be used with implanted programmable pumps","volume":"8","author":"Ilias","year":"2008","journal-title":"Pain Pract"},{"key":"10.1111\/ner.12146_bib32","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/BF03011037","article-title":"Side effects of intrathecal and epidural opioids","volume":"42","author":"Chaney","year":"1995","journal-title":"Can J Anaesth"},{"key":"10.1111\/ner.12146_bib33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00006123-199902000-00026","article-title":"A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain","volume":"44","author":"Anderson","year":"1999","journal-title":"Neurosurgery"},{"key":"10.1111\/ner.12146_bib34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3171\/jns.1996.85.3.0458","article-title":"Long-term effects of continuous intrathecal opioid treatment in chronic pain of non-malignant etiology","volume":"85","author":"Winkelmuller","year":"1996","journal-title":"J Neurosurg"},{"key":"10.1111\/ner.12146_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00000542-199307000-00010","article-title":"Dose-response pharmacology of intrathecal morphine in human volunteers","volume":"79","author":"Bailey","year":"1993","journal-title":"Anesthesiology"},{"key":"10.1111\/ner.12146_bib36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1526-4637.2001.01052.x","article-title":"Intrathecal hydromorphone for chronic nonmalignant pain: a retrospective study","volume":"2","author":"Anderson","year":"2001","journal-title":"Pain Med"},{"key":"10.1111\/ner.12146_bib37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1053\/eujp.2000.0199","article-title":"Leg edema from intrathecal opiate infusions","volume":"4","author":"Aldrete","year":"2000","journal-title":"Eur J Pain"},{"key":"10.1111\/ner.12146_bib38","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1210\/jcem.85.6.6615","article-title":"Endocrine consequences of long-term intrathecal administration of opioids","volume":"85","author":"Abs","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/ner.12146_bib39","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/00000542-200003000-00018","article-title":"Comparative spinal distribution and clearance kinetics of intrathecally administered morphine, fentanyl, alfentanil, and sufentanil","volume":"92","author":"Ummenhofer","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1111\/ner.12146_bib40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.36076\/ppj.2007\/10\/357","article-title":"Drug-related side effects of long-term intrathecal morphine therapy","volume":"10","author":"Ruan","year":"2007","journal-title":"Pain Physician"},{"key":"10.1111\/ner.12146_bib41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2147\/TCRM.S4438","article-title":"Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain","volume":"5","author":"Smith","year":"2009","journal-title":"Therap Clin Risk Manage"},{"key":"10.1111\/ner.12146_bib42","series-title":"NDA 21-060: labeling supplement Prialt\u00ae (ziconotide intrathecal infusion)","year":"2004"},{"key":"10.1111\/ner.12146_bib43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1525-1403.2005.05232.x","article-title":"A consensus statement regarding the present suggested titration for Prialt (ziconotide)","volume":"8","author":"Fisher","year":"2005","journal-title":"Neuromodulation"},{"key":"10.1111\/ner.12146_bib44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1525-1403.2006.00055.x","article-title":"Intrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trial","volume":"9","author":"Wallace","year":"2006","journal-title":"Neuromodulation"},{"key":"10.1111\/ner.12146_bib45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpainsymman.2005.10.003","article-title":"A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain","volume":"31","author":"Rauck","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/ner.12146_bib46","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1097\/00000542-200406000-00034","article-title":"Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections","volume":"100","author":"Follett","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1111\/ner.12146_bib47","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1086\/501620","article-title":"Guideline for prevention of surgical site infection, 1999","volume":"20","author":"Mangram","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/ner.12146_bib48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1056\/NEJMoa0810988","article-title":"Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis","volume":"362","author":"Darouiche","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/ner.12146_bib49","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/jac\/dkr009","article-title":"The role of topical antibiotics used as prophylaxis in surgical site infection prevention","volume":"66","author":"McHugh","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/ner.12146_bib50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/01.ASW.0000428861.26671.41","article-title":"Wound cleaning and wound healing: a concise review","volume":"26","author":"Wilkins","year":"2013","journal-title":"Adv Skin Wound Care"},{"key":"10.1111\/ner.12146_bib51","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/PRS.0b013e3181addc68","article-title":"Protective effect of topical antibiotics in breast augmentation","volume":"124","author":"Pfeiffer","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"10.1111\/ner.12146_bib52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1525-1403.2003.03005.x","article-title":"Prevention of intrathecal drug delivery catheter-related complications","volume":"6","author":"Follett","year":"2003","journal-title":"Neuromodulation"},{"key":"10.1111\/ner.12146_bib53","unstructured":"Clinical Reference Guide. 2013. http:\/\/professional.medtronic.com\/wcm\/groups\/mdtcom_sg\/@mdt\/@neuro\/documents\/documents\/synchii-ref-guide.pdf Accessed April 20, 2013."},{"key":"10.1111\/ner.12146_bib54","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/01.ajp.0000210955.93878.44","article-title":"Programmable intrathecal opioid delivery systems for chronic noncancer pain: a systematic review of effectiveness and complications","volume":"23","author":"Turner","year":"2007","journal-title":"Clin J Pain"},{"key":"10.1111\/ner.12146_bib55","doi-asserted-by":"crossref","first-page":"291","DOI":"10.36076\/ppj.2005\/8\/291","article-title":"The diagnosis of intrathecal infusion pump system failure","volume":"8","author":"Jones","year":"2005","journal-title":"Pain Physician"},{"key":"10.1111\/ner.12146_bib56","series-title":"Pump corrosion from nonindicated drug formulations resulting in permanent pump stalls","year":"2010"},{"key":"10.1111\/ner.12146_bib57","series-title":"Use of unapproved drugs with the Synchromed\u00ae implantable infusion pump","year":"2012"},{"key":"10.1111\/ner.12146_bib58","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00000542-200607000-00027","article-title":"Cerebrospinal fluid and spinal cord distribution of baclofen and bupivacaine during slow intrathecal infusion in pigs","volume":"105","author":"Bernards","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1111\/ner.12146_bib59","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1213\/ANE.0b013e318203b7c0","article-title":"Morphine distribution in the spinal cord after chronic infusion in pigs","volume":"112","author":"Flack","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1111\/ner.12146_bib60","series-title":"Basic neurochemistry\u2014molecular, cellular and medical aspects","first-page":"672","article-title":"Blood-brain-cerebrospinal fluid barriers","author":"Laterra","year":"1999"},{"key":"10.1111\/ner.12146_bib61","series-title":"Important clinical information about pocket fills","year":"2011"},{"key":"10.1111\/ner.12146_bib62","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1526-4637.2011.01090.x","article-title":"Ultrasound-guided intrathecal pump access and prevention of the pocket fill","volume":"12","author":"Gofeld","year":"2011","journal-title":"Pain Med"},{"key":"10.1111\/ner.12146_bib63","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1227\/01.NEU.0000129698.73730.E4","article-title":"Correlation between withdrawal symptoms and medication pump residual volume in patients with implantable SynchroMed pumps","volume":"55","author":"Taha","year":"2004","journal-title":"Neurosurgery"},{"key":"10.1111\/ner.12146_bib64","first-page":"233","article-title":"Best-practice surgical techniques for intrathecal baclofen therapy","volume":"104","author":"Albright","year":"2006","journal-title":"J Neurosurg"},{"key":"10.1111\/ner.12146_bib65","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1227\/00006123-199111000-00025","article-title":"Spinal cord compression complicating subarachnoid infusion of morphine: case report and laboratory experience","volume":"29","author":"North","year":"1991","journal-title":"Neurosurgery"},{"key":"10.1111\/ner.12146_bib66","series-title":"Updated information\u2014inflammatory mass (granuloma) at or near the distal tip of intrathecal catheters","year":"2008"},{"key":"10.1111\/ner.12146_bib67","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1525-1403.2012.00449.x","article-title":"Polyanalgesic consensus conference\u20142012 consensus on diagnosis, detection, and treatment of catheter-tip granulomas (inflammatory masses)","volume":"15","author":"Deer","year":"2012","journal-title":"Neuromodulation"},{"key":"10.1111\/ner.12146_bib68","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1526-4637.2002.02048.x","article-title":"Inflammatory masses associated with intrathecal drug infusion, a review of preclinical evidence and human data","volume":"3","author":"Yaksh","year":"2002","journal-title":"Pain Med"},{"key":"10.1111\/ner.12146_bib69","first-page":"78","article-title":"Inflammatory mass lesions associated with intrathecal drug infusion catheters: report and observations in 41 patients","volume":"50","author":"Coffey","year":"2002","journal-title":"Neurosurgery"},{"key":"10.1111\/ner.12146_bib70","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1525-1403.2008.00147.x","article-title":"Management of intrathecal catheter-tip inflammatory masses: an updated 2007 consensus statement from an expert panel","volume":"11","author":"Deer","year":"2008","journal-title":"Neuromodulation"},{"key":"10.1111\/ner.12146_bib71","series-title":"MRI guidelines","year":"2010"},{"key":"10.1111\/ner.12146_bib72","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1525-1403.1999.00092.x","article-title":"Drug adverse events and system complications of intrathecal opioid delivery for pain: origins, detection, manifestations, and management","volume":"2","author":"Naumann","year":"1999","journal-title":"Neuromodulation"},{"key":"10.1111\/ner.12146_bib73","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00002508-200109000-00004","article-title":"Evaluation of patients for implantable pain modalities: medical and behavioral assessment","volume":"17","author":"Prager","year":"2001","journal-title":"Clin J Pain"},{"key":"10.1111\/ner.12146_bib74","series-title":"The skin senses","first-page":"432","article-title":"Sensory, motivational and central determinants of chronic pain: a new conceptual model","author":"Melzack","year":"1968"},{"key":"10.1111\/ner.12146_bib75","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pain.2007.03.032","article-title":"Transition from acute to chronic pain and disability: a model including cognitive, affective, and trauma factors","volume":"134","author":"Young-Casey","year":"2008","journal-title":"Pain"},{"key":"10.1111\/ner.12146_bib76","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/1529-0131(200003)43:3<561::AID-ANR12>3.0.CO;2-O","article-title":"The association between chronic widespread pain and mental disorder: a population-based study","volume":"43","author":"Benjamin","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1111\/ner.12146_bib77","doi-asserted-by":"crossref","unstructured":"Eccleston CW, Williams AC, Morley S. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev 2011;(2). DOI: 10.1002\/14651858.CD007407.pub2.","DOI":"10.1002\/14651858.CD007407.pub3"},{"key":"10.1111\/ner.12146_bib78","series-title":"Psychosocial interventions for chronic pain: in search of evidence","author":"Roy","year":"2008"},{"key":"10.1111\/ner.12146_bib79","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1533-2500.2006.00069.x","article-title":"Does a combination of intensive cognitive-behavioral pain management and a spinal implantable device confer any advantage? A preliminary examination","volume":"6","author":"Molloy","year":"2006","journal-title":"Pain Pract"},{"key":"10.1111\/ner.12146_bib80","series-title":"Chronic pain: an integrated biobehavioral approach","author":"Flor","year":"2011"},{"key":"10.1111\/ner.12146_bib81","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/1468-0009.00078","article-title":"Supply dynamics of the mental health workforce: implications for health policy","volume":"76","author":"Ivey","year":"1998","journal-title":"Milbank Q"},{"key":"10.1111\/ner.12146_bib82","doi-asserted-by":"crossref","first-page":"23","DOI":"10.36076\/ppj.2010\/13\/23","article-title":"Considerations and methodology for trialing ziconotide","volume":"13","author":"Burton","year":"2010","journal-title":"Pain Physician"}],"container-title":["Neuromodulation: Technology at the Neural Interface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fner.12146","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715914600878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094715914600878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ner.12146\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:50:45Z","timestamp":1761083445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094715914600878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1094715914600878"],"URL":"https:\/\/doi.org\/10.1111\/ner.12146","relation":{},"ISSN":["1094-7159"],"issn-type":[{"value":"1094-7159","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Best Practices for Intrathecal Drug Delivery for Pain","name":"articletitle","label":"Article Title"},{"value":"Neuromodulation: Technology at the Neural Interface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ner.12146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 International Neuromodulation Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}